These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. What is the optimal timing of liver transplantation for children with biliary atresia? A Markov model simulation analysis. Arnon R, Leshno M, Annunziato R, Florman S, Iyer K. J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):398-402. PubMed ID: 24821536 [Abstract] [Full Text] [Related]
29. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Liver Transpl; 2005 Oct; 11(10):1193-200. PubMed ID: 16184564 [Abstract] [Full Text] [Related]
31. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults. Kyoden Y, Tamura S, Sugawara Y, Yamashiki N, Matsui Y, Togashi J, Kaneko J, Kokudo N, Makuuchi M. Liver Transpl; 2008 Feb; 14(2):186-92. PubMed ID: 18236393 [Abstract] [Full Text] [Related]
32. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort. van der Doef HPJ, van Rheenen PF, van Rosmalen M, Rogiers X, Verkade HJ, for pediatric liver transplantation centers of Eurotransplant. Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411 [Abstract] [Full Text] [Related]
33. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Anouti A, Patel MS, VanWagner LB, Lee WM, Fung JJ, Cholankeril G, Hwang CS, Mufti AR, Tujios S, Kerr T, Rich NE, Louissaint J, Desai DM, Vagefi PA, Hanish S, Shah J, Singal AG, Cotter TG. Liver Int; 2023 Oct; 43(10):2198-2209. PubMed ID: 37548078 [Abstract] [Full Text] [Related]
34. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562 [Abstract] [Full Text] [Related]
35. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Barshes NR, Lee TC, Udell IW, O'mahoney CA, Karpen SJ, Carter BA, Goss JA. Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644 [Abstract] [Full Text] [Related]
37. Paediatric living donor liver transplantation. Botha JF. S Afr Med J; 2012 Sep 11; 102(11 Pt 2):879-80. PubMed ID: 23116749 [Abstract] [Full Text] [Related]
38. Incidence, impact, and treatment of portal and hepatic venous complications following pediatric liver transplantation: a single-center 12 year experience. Heffron TG, Pillen T, Smallwood G, Henry S, Sekar S, Casper K, Solis D, Tang W, Fasola C, Romero R. Pediatr Transplant; 2010 Sep 01; 14(6):722-9. PubMed ID: 20345612 [Abstract] [Full Text] [Related]
39. The influence of portoenterostomy on transplantation for biliary atresia. Visser BC, Suh I, Hirose S, Rosenthal P, Lee H, Roberts JP, Hirose R. Liver Transpl; 2004 Oct 01; 10(10):1279-86. PubMed ID: 15376306 [Abstract] [Full Text] [Related]
40. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis. Stewart ZA, Locke JE, Montgomery RA, Singer AL, Cameron AM, Segev DL. Liver Transpl; 2009 Aug 01; 15(8):883-93. PubMed ID: 19642117 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]